Galapagos (GLPG) stock dips as Morgan Stanley downgrades its rating to Underweight from Equal Weight amid its CAR-T therapy ...

In a report released on February 13, Brian Abrahams from RBC Capital maintained a Hold rating on Galapagos (GLPG – Research Report), with a ...

In a report released on February 13, Christophe dombu from Kepler Capital maintained a Sell rating on Galapagos (0JXZ – Research Report), with ...

Galapagos NV (GLPG) reports strong financials and strategic advancements amid increased R&D expenses and operational ...

Galapagos is dropping its junior CD19 CAR-T as part of the Belgian biotech’s seemingly never-ending mission to recalibrate ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

In its annual results statement, Galapagos chief financial officer Thad Huston said the firm is moving ahead with a planned ...

CEO Paul Stoffels highlighted 2024 as a pivotal year for Galapagos, emphasizing the FDA IND clearance for GLPG5101 and strong results from the ATALANTA study in non-Hodgkin lymphoma. He outlined the ...

"ZooEarthTV brings you incredible animal interactions, amazing wildlife moments, and stunning travel destinations from around ...

Undersea mountains are key locations for predators—with 41 times more sharks than the open ocean, new research shows.

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein ...

Galapagos Tortoises are among the most iconic animals in the world. Extremely rare, they exist naturally only on the ...